BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was PLN 12 million compared to PLN 8.62 million a year ago. Net income was PLN 0.742 million compared to net loss of PLN 0.484 million a year ago.

Basic earnings per share from continuing operations was PLN 0.01 compared to basic loss per share from continuing operations of PLN 0.01 a year ago. Diluted earnings per share from continuing operations was PLN 0.01 compared to diluted loss per share from continuing operations of PLN 0.01 a year ago.